AU7264287A - A process for the preparation of a factor V concentrate - Google Patents

A process for the preparation of a factor V concentrate

Info

Publication number
AU7264287A
AU7264287A AU72642/87A AU7264287A AU7264287A AU 7264287 A AU7264287 A AU 7264287A AU 72642/87 A AU72642/87 A AU 72642/87A AU 7264287 A AU7264287 A AU 7264287A AU 7264287 A AU7264287 A AU 7264287A
Authority
AU
Australia
Prior art keywords
concentrate
factor
preparation
concentration
anticoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU72642/87A
Other versions
AU610823B2 (en
Inventor
Norbert Heimburger
Gerhardt Kumpe
Wilfried Wormsbacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU7264287A publication Critical patent/AU7264287A/en
Application granted granted Critical
Publication of AU610823B2 publication Critical patent/AU610823B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

There is described a process for preparing a clotting factor V concentrate, in which such a concentrate of blood plasma or a fraction of blood plasma containing an anticoagulant is prepared by adding a salt of a divalent metal in such an amount that the concentration of divalent cations is smaller than the concentration equivalent to the concentration of anticoagulant.
AU72642/87A 1986-05-09 1987-05-08 A process for the preparation of a factor V concentrate Ceased AU610823B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3615558 1986-05-09
DE19863615558 DE3615558A1 (en) 1986-05-09 1986-05-09 METHOD FOR PRODUCING A FACTOR V CONCENTRATE

Publications (2)

Publication Number Publication Date
AU7264287A true AU7264287A (en) 1987-11-12
AU610823B2 AU610823B2 (en) 1991-05-30

Family

ID=6300403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72642/87A Ceased AU610823B2 (en) 1986-05-09 1987-05-08 A process for the preparation of a factor V concentrate

Country Status (7)

Country Link
EP (1) EP0244834B1 (en)
JP (1) JP2540541B2 (en)
AT (1) ATE73667T1 (en)
AU (1) AU610823B2 (en)
CA (1) CA1293214C (en)
DE (2) DE3615558A1 (en)
ES (1) ES2031849T3 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DE4418635C2 (en) * 1994-05-27 1997-07-24 Immuno Ag Pharmaceutical composition for the prevention and treatment of bleeding disorders
DE69804216T2 (en) 1997-06-05 2002-11-07 Global Hemostasis Inst Mgr Ab PREVENTION OF COAGULATION OF BLOOD, BLOOD PLASMA OR synovial fluid
SE9804248D0 (en) * 1998-12-07 1998-12-07 Global Hemostasis Inst Mgr Ab Anti-coagulation with calcium containing citrate solution
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
WO2006086200A1 (en) 2005-02-07 2006-08-17 Hanuman Llc Plasma concentrator device
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US10106587B2 (en) 2008-02-27 2018-10-23 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
ITFI20110084A1 (en) * 2011-04-22 2012-10-23 Kedrion Spa NEW PROCESS FOR THE PREPARATION OF A FV VIRUS CONCENTRATE INACTIVATED STARTING FROM HUMAN PLASMA, SCALABLE AT INDUSTRIAL LEVEL.
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101752A1 (en) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "METHOD FOR PURIFYING THE BLOOD COAGINING FACTORS II, VII, IX AND / OR X AND PREPARATIONS PRODUCED THEREFORE"

Also Published As

Publication number Publication date
JP2540541B2 (en) 1996-10-02
JPS62267235A (en) 1987-11-19
EP0244834A2 (en) 1987-11-11
AU610823B2 (en) 1991-05-30
DE3777440D1 (en) 1992-04-23
EP0244834A3 (en) 1989-01-04
CA1293214C (en) 1991-12-17
ES2031849T3 (en) 1993-01-01
ATE73667T1 (en) 1992-04-15
EP0244834B1 (en) 1992-03-18
DE3615558A1 (en) 1987-11-12

Similar Documents

Publication Publication Date Title
AU7264287A (en) A process for the preparation of a factor V concentrate
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
IE822602L (en) Stabilized aqueous insulin solutions
JPS55100319A (en) Plasma fractration stabilized by citrate
AU544157B2 (en) Production of stable blood clotting factors ix + x by warming with calcium ions
ES544209A0 (en) PROCEDURE FOR THE SPECIFIC ADSORPTION OF HEPARIN
AU7371587A (en) Peptides that inhibit binding of Von Willebrand factor binding
DE3167338D1 (en) Stabilisation of factor viii activity in blood plasma
DE3877338T2 (en) ISOLATION OF AN IMMUNOGLOBULIN-rich whey fraction.
ES532641A0 (en) PROCEDURE FOR THE PREPARATION OF AN ANTITHROMBINE III-HEPARIN CONCENTRATE OR ANTITHROMBINE III-HEPARINOID
AU585216B2 (en) Process for the microbiological preparation of l-carnitine
AU6905287A (en) A method for the determination of microbe concentrations by means of a plating method and dishes used therein
ES8306406A1 (en) Method and composition for determining glycosylated hemoglobin.
DE2962725D1 (en) Anticoagulant agent, process for the preparation thereof and pharmaceutical preparations containing same
GB2161800B (en) Water soluble compositions for preparing analytical solutions
EP0367475A3 (en) Process for producing haemoglobin concentrate
NZ216447A (en) Wood treating composition based on a copper salt
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
Amiraian et al. Effect of zinc and cadmium on guinea-pig complement
ES502498A0 (en) PROCEDURE TO PREPARE A SAN-GUINEA COAGULATION COMPLEX
AU3697189A (en) Method for the determination of lipid-bound sialic acid content of blood
AU545065B2 (en) Pharmaceutical formulations containing prostaglandin
PL234615A1 (en) Method of determination of changes of concentration of solution,especially transparent or translucent one
AU8803891A (en) Thrombin-binding substance and process for preparing the same